Skip to main navigation Skip to search Skip to main content

Innovative pharmacologic approaches to eating disorder treatment

  • Aaron Keshen
  • , Stephen Touyz
  • , Emilie Lacroix
  • , Phillipa Hay
  • , Susan L. McElroy
  • Dalhousie University
  • The University of Sydney
  • University of New Brunswick
  • University of Cincinnati
  • Lindner Center of HOPE

Research output: Contribution to journalArticlepeer-review

Abstract

Eating disorders, including anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), and avoidant/restrictive food intake disorder (ARFID) are complex psychiatric conditions characterized by severe disturbances in eating behaviors and associated psychological distress. These disorders often co-occur with medical complications, psychiatric comorbidities, and functional impairments, leading to an impact on quality of life and increased mortality rates. Despite their high prevalence and substantial burden, treatment outcomes for eating disorders remain suboptimal.
Original languageEnglish
Pages (from-to)203-216
Number of pages14
JournalPsychiatric Clinics of North America
Volume49
Issue number1
DOIs
Publication statusPublished - Mar 2026

Bibliographical note

Publisher Copyright:
© 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Keywords

  • Anorexia nervosa
  • Avoidant/restrictive food intake disorder
  • Binge-eating disorder
  • Bulimia nervosa
  • Eating disorders
  • Pharmacotherapy
  • Psychedelics
  • Stimulant medications

Fingerprint

Dive into the research topics of 'Innovative pharmacologic approaches to eating disorder treatment'. Together they form a unique fingerprint.

Cite this